Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanopsin-containing intrinsically photosensitive retinal ganglion cells (ipRGCs) are a rare subset (~3–5%) of mammalian retinal ganglion cells that express the photopigment melanopsin. Unlike classical photoreceptors—rods and cones—ipRGCs can respond directly to light due to melanopsin-mediated intrinsic photosensitivity. They integrate this intrinsic response with synaptic input from rods/cones via bipolar/amacrine cells. ipRGCs project axons both within the retina and centrally into brain regions involved in non-image-forming vision—including the suprachiasmatic nucleus for circadian rhythm entrainment, olivary pretectal nucleus for pupillary constriction reflexes, dorsal lateral geniculate nucleus for image formation modulation, among others. Multiple subtypes exist (M1 through M6), each with distinct morphology and functional roles ranging from regulating biological clocks to influencing mood by modulating brain activity according to ambient lighting conditions. Their discovery has reshaped understanding of how environmental lighting affects physiology beyond traditional vision pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanopsin-containing intrinsically photosensitive retinal ganglion cell (ipRGC).